Diferido
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,275 USD | +2,46 % | -12,36 % | -39,56 % |
Resumen de negocios
Número de empleados: 6
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Allen Baharaff
CEO | Chief Executive Officer | 59 | 01/01/00 |
Doron Cohen
DFI | Director of Finance/CFO | 57 | 01/02/22 |
Guy Nehemya
COO | Chief Operating Officer | 39 | 01/10/13 |
Liat Hayardeny
CTO | Chief Tech/Sci/R&D Officer | 57 | 07/09/16 |
Yohai Stenzler
AUD | Comptroller/Controller/Auditor | 41 | 01/06/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | 01/06/14 |
Carol Brosgart
BRD | Director/Board Member | 72 | 07/06/17 |
Allen Baharaff
CEO | Chief Executive Officer | 59 | 01/01/00 |
Shmuel Nir
BRD | Director/Board Member | 62 | 01/01/07 |
Amir Poshinski
BRD | Director/Board Member | 63 | 16/06/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 6 358 747 | 6 126 245 ( 96,34 %) | 0 | 96,34 % |
Información de la empresa
Galmed Pharmaceuticals Ltd.
16 Abba Hillel Road
5250608, Ramat Gan
+972 3 693 8448
http://galmedpharma.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-39,56 % | 1,75 M | |
+15,20 % | 121 mil M | |
+19,67 % | 113 mil M | |
+16,65 % | 26,02 mil M | |
-23,86 % | 19,39 mil M | |
-19,77 % | 15,91 mil M | |
-20,90 % | 15,09 mil M | |
-46,14 % | 15,06 mil M | |
+63,85 % | 14,93 mil M | |
+4,49 % | 13,85 mil M |
- Bolsa de valores
- Acciones
- Acción GLMD
- Empresa Galmed Pharmaceuticals Ltd.